189 related articles for article (PubMed ID: 27069116)
41. TCR-dependent transformation of mature memory phenotype T cells in mice.
Wang X; Werneck MB; Wilson BG; Kim HJ; Kluk MJ; Thom CS; Wischhusen JW; Evans JA; Jesneck JL; Nguyen P; Sansam CG; Cantor H; Roberts CW
J Clin Invest; 2011 Oct; 121(10):3834-45. PubMed ID: 21926465
[TBL] [Abstract][Full Text] [Related]
42. New insights in the pathogenesis of T-cell lymphomas.
Lemonnier F; Gaulard P; de Leval L
Curr Opin Oncol; 2018 Sep; 30(5):277-284. PubMed ID: 30028743
[TBL] [Abstract][Full Text] [Related]
43. Challenges and implications of genomics for T-cell lymphomas.
Jacobsen ED; Weinstock DM
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):63-68. PubMed ID: 30504292
[TBL] [Abstract][Full Text] [Related]
44. Activation of T-cell receptor signaling in peripheral T-cell lymphoma cells plays an important role in the development of lymphoma-associated hemophagocytosis.
An J; Fujiwara H; Suemori K; Niiya T; Azuma T; Tanimoto K; Ochi T; Akatsuka Y; Mineno J; Ozawa H; Ishikawa F; Kuzushima K; Yasukawa M
Int J Hematol; 2011 Feb; 93(2):176-185. PubMed ID: 21229399
[TBL] [Abstract][Full Text] [Related]
45. Pathogenesis of Peripheral T Cell Lymphoma.
Pizzi M; Margolskee E; Inghirami G
Annu Rev Pathol; 2018 Jan; 13():293-320. PubMed ID: 29414251
[TBL] [Abstract][Full Text] [Related]
46. Characterization of a new mouse model for peripheral T cell lymphoma in humans.
Beyersdorf N; Werner S; Wolf N; Herrmann T; Kerkau T
PLoS One; 2011; 6(12):e28546. PubMed ID: 22163033
[TBL] [Abstract][Full Text] [Related]
47. VAV1 mutations contribute to development of T-cell neoplasms in mice.
Fukumoto K; Sakata-Yanagimoto M; Fujisawa M; Sakamoto T; Miyoshi H; Suehara Y; Nguyen TB; Suma S; Yanagimoto S; Shiraishi Y; Chiba K; Bouska A; Kataoka K; Ogawa S; Iqbal J; Ohshima K; Chiba S
Blood; 2020 Dec; 136(26):3018-3032. PubMed ID: 32992343
[TBL] [Abstract][Full Text] [Related]
48. Activated granulocytes and inflammatory cytokine signaling drive T-cell lymphoma progression and disease symptoms.
Jaeger A; Gambheer SMM; Sun X; Chernyakov D; Skorobohatko O; Mack T; Kissel S; Pfeifer D; Zeiser R; Fisch P; Andrieux G; Bräuer-Hartmann D; Bauer M; Schulze S; Follo M; Boerries M; von Bubnoff N; Miething C; Hidalgo JV; Klein C; Weber T; Wickenhauser C; Binder M; Dierks C
Blood; 2023 Jun; 141(23):2824-2840. PubMed ID: 36696631
[TBL] [Abstract][Full Text] [Related]
49. Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma.
Beachy SH; Onozawa M; Chung YJ; Slape C; Bilke S; Francis P; Pineda M; Walker RL; Meltzer P; Aplan PD
Blood; 2012 Aug; 120(5):1048-59. PubMed ID: 22723554
[TBL] [Abstract][Full Text] [Related]
50. New molecular insights into peripheral T cell lymphomas.
Pileri SA; Piccaluga PP
J Clin Invest; 2012 Oct; 122(10):3448-55. PubMed ID: 23023716
[TBL] [Abstract][Full Text] [Related]
51. Pathology and Pathogenesis of T-Cell Lymphoma.
Vega F
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20 Suppl 1():S89-S93. PubMed ID: 32862884
[TBL] [Abstract][Full Text] [Related]
52. Peripheral T cell lymphomas: from the bench to the clinic.
Fiore D; Cappelli LV; Broccoli A; Zinzani PL; Chan WC; Inghirami G
Nat Rev Cancer; 2020 Jun; 20(6):323-342. PubMed ID: 32249838
[TBL] [Abstract][Full Text] [Related]
53. T-cell receptor signaling in peripheral T-cell lymphoma - a review of patterns of alterations in a central growth regulatory pathway.
Warner K; Weit N; Crispatzu G; Admirand J; Jones D; Herling M
Curr Hematol Malig Rep; 2013 Sep; 8(3):163-72. PubMed ID: 23892905
[TBL] [Abstract][Full Text] [Related]
54. Biology and Molecular Pathogenesis of Mature T-Cell Lymphomas.
Cortés JR; Palomero T
Cold Spring Harb Perspect Med; 2021 May; 11(5):. PubMed ID: 32513675
[TBL] [Abstract][Full Text] [Related]
55. Targets, Toxins, and T Cells--a Review of New Monoclonal Antibodies in the Treatment of Peripheral T Cell Lymphomas.
Hebb J; Kohrt H
Curr Hematol Malig Rep; 2015 Dec; 10(4):438-47. PubMed ID: 26433890
[TBL] [Abstract][Full Text] [Related]
56. Evolving Strategies for the Treatment of T-Cell Lymphoma: A Systematic Review and Recent Patents.
Laribi K; Alani M; Truong C; de Materre AB
Recent Pat Anticancer Drug Discov; 2018; 13(3):308-340. PubMed ID: 29769011
[TBL] [Abstract][Full Text] [Related]
57. Peripheral T-Cell Lymphomas: Therapeutic Approaches.
Sibon D
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565460
[TBL] [Abstract][Full Text] [Related]
58. TCR Pathway Mutations in Mature T Cell Lymphomas.
Zhang Y; Cheng K; Choi J
J Immunol; 2023 Nov; 211(10):1450-1458. PubMed ID: 37931208
[TBL] [Abstract][Full Text] [Related]
59. Biology and management of rare primary extranodal T-cell lymphomas.
Roschewski M; Wilson WH
Oncology (Williston Park); 2010 Jan; 24(1):94-100. PubMed ID: 20187328
[TBL] [Abstract][Full Text] [Related]
60. Cytoskeleton Dynamics in Peripheral T Cell Lymphomas: An Intricate Network Sustaining Lymphomagenesis.
Fragliasso V; Tameni A; Inghirami G; Mularoni V; Ciarrocchi A
Front Oncol; 2021; 11():643620. PubMed ID: 33928032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
